Also trades as: NSHS.CN (CNQ) · $vol 0M
NSHSF OTC
NanoSphere Health Sciences Inc.
1W: +0.0%
1M: +0.0%
3M: +4.2%
YTD: -24.2%
1Y: -50.0%
3Y: -9.1%
5Y: -98.1%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$169K
+23.3% ▲
Net Income
$263
+100.1% ▲
EPS (Diluted)
$0.02
+209.9% ▲
EBITDA
$252K
+2164.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -100.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $14K | $0 | $0 | $0 | $0 |
| Gross Profit | -$14K | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $60K | $27K | $23K | $9 |
| SG&A Expenses | $533K | $297K | $257K | $197K | $160K |
| Operating Expenses | $581K | $383K | $273K | $220K | $169 |
| Operating Income | -$530K | -$355K | -$263K | -$220K | -$169K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $2K |
| Income Before Tax | -$591K | -$356K | -$282K | -$228K | $263 |
| Tax Expense | $0 | $0 | $0 | -$8 | $0 |
| Net Income | -$591K | -$356K | -$282K | -$228K | $263 |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.11 | $-0.05 | $-0.03 | $-0.02 | $0.02 |
| EBITDA | -$530K | -$341K | -$271K | -$12K | $252K |
| Shares Outstanding | 5M | 7M | 10M | 10M | 10M |